Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases
Dasia Aldarondo, Elizabeth Wayne
Abstract
Due to the increasing population of individuals with cardiovascular diseases and related comorbidities, there is an increasing need for development of synergistic therapeutics. Monocytes are implicated in a broad spectrum of diseases and can serve as a focal point for therapeutic targeting. This review discusses the role of monocytes in cardiovascular diseases and highlights trends in monocyte targets nanoparticles in three cardiovascular-related diseases: Diabetes, Atherosclerosis, and HIV. Finally, the review offers perspectives on how to develop nanoparticle monocyte targeting strategies that can be beneficial for treating co-morbidities.
Topics & Concepts
MedicineMonocyteDiabetes mellitusPopulationHuman immunodeficiency virus (HIV)Global populationImmunologyBioinformaticsBiologyEndocrinologyEnvironmental healthImmune cells in cancerAdipokines, Inflammation, and Metabolic DiseasesNeuroinflammation and Neurodegeneration Mechanisms